Profiel
Stephen S.
Yoder is currently Co-Managing Director at Pieris Pharmaceuticals GmbH.
Former positions include President & Chief Executive Officer at Marika, Inc., President, Chief Executive Officer & Director at Pieris AG, President, Chief Executive Officer & Director at Pieris Pharmaceuticals, Inc. from 2014 to 2024, Chief Executive Officer at Palvella Therapeutics, Inc., and General Counsel at MorphoSys AG from 1999 to 2010.
Education includes undergraduate studies at Grove City College and graduate studies at George Washington University Law School.
Actieve functies van Stephen Yoder
| Bedrijven | Functie | Begin |
|---|---|---|
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Operates as a biotechnology company | Algemeen Directeur | - |
Eerdere bekende functies van Stephen Yoder
| Bedrijven | Functie | Einde |
|---|---|---|
| PIERIS PHARMACEUTICALS | Algemeen Directeur | 13-12-2024 |
| MORPHOSYS AG | Algemeen Adviseur | - |
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Provides online job marketplace services | Algemeen Directeur | - |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Algemeen Directeur | - |
Opleiding van Stephen Yoder
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Provides online job marketplace services | Commercial Services |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Grove City College
Grove City College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
George Washington University Law School
George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















